Published on 01 January 2022

A Phase III, Multicentre, Prospective, Open Label Extension Study to Assess the Long Term Safety and Efficacy of Repeated Treatment of Dysport® Intramuscular Injections Used for the Treatment of Upper Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury

Ipsen

Description

The purpose of this research study is to assess the long term safety of Dysport® in hemiparetic subjects with upper limb spasticity due to stroke or traumatic brain injury over repeated treatment cycles.

Citations (0)

No citations found

It looks like this dataset has no citations.

Mentions (0)

No mentions found

It looks like this dataset has not been mentioned in any sources.

Metrics

Dataset Index

0.7

FAIR Score

31%

Citations

Mentions

Metrics Over Time

Publication Details

DOI

10.25934/pr00008359

Publisher

Vivli

Assigned Domain

Subfield

Pharmacology

Field

Medicine

Domain

Health Sciences

Confidence Score

86%

Source

Open Alex

Keywords

Conditions: Nervous System DisordersInterventions: Botulinum toxin type A

Normalization Factors

15.38

CTw

1.00

MTw

1.00